Benign prostatic hyperplasia (BPH) affects millions of men globally and remains one of the most common age-related urological conditions. For many, the early signs are often misunderstood or dismissed as a normal part of ageing. Left unmanaged, however, benign prostatic hyperplasia BPH may significantly reduce urinary function and quality of life.
Understanding the underlying causes and symptoms of this condition is essential in preventing its complications. A structured medical evaluation followed by appropriate intervention may prevent long-term issues.
Benign prostatic hyperplasia is a condition characterised by the non-cancerous enlargement of the prostate gland. This gland surrounds the urethra and lies below the bladder. As the prostate grows, it may begin to compress the urethra, leading to urinary disturbances.
Histologically, the growth results from cellular hyperplasia rather than inflammation or tumour formation. Despite its benign nature, the associated symptoms may cause considerable distress if not diagnosed and managed early.
With advancing age, almost all individuals with a prostate are at risk of developing some degree of enlargement. The condition is especially prevalent among individuals aged 50 and above. The severity of benign prostatic hyperplasia symptoms may vary, and the gland’s size may not directly correlate with symptom intensity. “What is benign prostatic hyperplasia?” is a question that frequently arises among those encountering its symptoms for the first time.
The symptoms of benign prostatic hyperplasia arise due to compression of the urethra, which results in a variety of lower urinary tract symptoms. The degree of urinary obstruction may vary [based on the location of the prostate growth and individual bladder response].
Benign prostatic hyperplasia symptoms may appear in the form of voiding problems or storage symptoms. Knowing about the mechanisms behind these changes can streamline early identification and risk reduction.
The presence of urine leakage after completing urination often reflects impaired bladder contraction or urethral resistance
The balance between testosterone and oestrogen shifts as men grow older. An increase in the active form of testosterone known as dihydrotestosterone plays a central role in stimulating cell growth in the prostate
Inflammation within prostate tissue may stimulate cytokines and growth factors that promote abnormal cellular proliferation
Individuals with a first-degree relative affected by benign prostatic hyperplasia are more likely to experience early or severe symptoms
Conditions such as insulin resistance, diabetes, and cardiovascular risk factors have been associated with increased prostate volume
Lifelong androgen exposure appears to be necessary for the development of benign prostatic hyperplasia. The prostate remains androgen-dependent throughout adulthood
The Diagnosis, Treatment, and Management of Benign Prostatic Hyperplasia
Early recognition and appropriate diagnostic workup may prevent complications such as urinary retention or bladder dysfunction. Once diagnosed, treatment is tailored based on severity of symptoms, prostate size, and risk of progression.
A detailed history of urinary symptoms should include onset, duration, frequency, and quality-of-life impact. A digital rectal examination helps assess prostate size and texture.
Tools such as the International Prostate Symptom Score are used to quantify the degree of urinary dysfunction and track progression over time.
Urinalysis may help detect infection, haematuria, or glycosuria. Kidney function testing helps exclude post-renal causes of dysfunction.
A bladder scan after urination may assess residual volume. Uroflowmetry measures the speed of urine flow and detects abnormalities.
Imaging may be conducted when complications are suspected. Prostate volume estimation may assist in deciding on treatment options.
Treatment:
Individuals with minor symptoms and no complications may be advised to monitor changes over time. Lifestyle adjustments may help in reducing symptom severity.
Medication may improve urine flow or reduce prostate size over a period of months. Drug classes may be chosen depending on prostate volume and symptom profile.
Various non-surgical procedures may relieve obstruction. These options are suitable for individuals who prefer short recovery periods and lower complication rates.
Surgical intervention may be necessary when urinary retention, bladder stones, or recurrent infections are present. Surgery removes or reshapes part of the prostate.
In cases where the bladder cannot be emptied, a catheter may be required. This is typically followed by medical therapy or surgical evaluation.
Periodic assessment ensures continued symptom control. Adjustments in treatment may be required if symptoms worsen or complications arise.
Although benign prostatic hyperplasia may not be entirely preventable, several measures may reduce its progression or delay the onset of symptoms. These approaches aim to improve metabolic health and reduce prostate tissue stimulation.
Obesity is a recognised risk factor for both onset and severity. Weight loss may reduce inflammation and hormonal imbalance
Regular exercise supports urinary tract health and helps regulate hormone levels. Sedentary behaviour may contribute to worsening symptoms
These substances may aggravate storage symptoms and should be limited especially in the evening
Proper management of metabolic risk factors may help reduce the impact on bladder and prostate tissue
Early detection may help initiate timely intervention and prevent complications. Screening is especially important in those with a family history
While mild urinary changes may not always indicate a serious issue, specific warning signs require immediate medical evaluation. The sudden inability to urinate, painful urination, or visible blood in urine must be addressed without delay. Individuals who experience frequent urinary tract infections or progressive worsening of symptoms should seek consultation.
Those uncertain about whether benign prostatic hyperplasia can become cancer should undergo appropriate screening to rule out malignancy. Consultation with the best urologists in Bangalore or visiting the best urology hospitals in Bangalore may support appropriate diagnosis and management.
Benign prostatic hyperplasia is a common condition that may impact urinary health in ageing individuals. Recognising the symptoms early, understanding the benign prostatic hyperplasia causes, and seeking appropriate medical attention are critical steps in maintaining quality of life.
The urinary complications may affect daily function and increase health risks if left unmanaged [while it is not cancerous]. Benign prostatic hyperplasia diagnosis often involves structured evaluation and, when required, a combination of pharmacological and surgical treatments. With the right care plan, individuals may effectively manage benign prostatic hyperplasia BPH and reduce the burden of symptoms.
Benign prostatic hyperplasia does not increase cancer risk. However, both may present with similar symptoms, and proper evaluation is essential to distinguish between them.
Benign prostatic hyperplasia primarily affects individuals over fifty years of age. The likelihood increases with age, and nearly all men develop some degree of enlargement.
Benign prostatic hyperplasia is not caused by an infection and cannot be transmitted from person to person. It is related to hormonal and age-related changes.
The best treatment depends on the severity of symptoms and presence of complications. Options include observation, medication, minimally invasive techniques, and surgery.
Hormonal changes associated with ageing are the most common cause. Additional risk factors include inflammation, obesity, and genetic predisposition.
3 Mins Read
Categories: Urology
Benign Prostatic Hyperplasia (BPH) - Symptoms and Causes is available for appointments. Please fill the below form to book an appointment.
Unlock the door to exceptional healthcare, book an appointment with SPARSH Hospital and let your journey to wellness begin.